Advancements in CRISPR screens for the development of cancer immunotherapy strategies.
Mol Ther Oncolytics
; 31: 100733, 2023 Dec 19.
Article
in En
| MEDLINE
| ID: mdl-37876793
Full text:
1
Database:
MEDLINE
Language:
En
Journal:
Mol Ther Oncolytics
Year:
2023
Type:
Article
Affiliation country:
United States